OpenVSafe by OpenVAERS
Search V-safe

34H-17866-42655

5 vaccinations 4 coded responses 33 check-ins 4 free-text entries 1 call case
Sex
Female
Age at first dose
66+
ZIP prefix
432 / OH
Registered
2021-02-12
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-02-12
    Registered in v-safe
  2. 2021-02-12
    Dose 1 — Moderna
  3. 2021-02-13
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  4. 2021-02-16
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache, Fatigue or tiredness
    Adult check-in
  5. 2021-02-17
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  6. 2021-02-21
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-02-26
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  8. 2021-03-05
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  9. 2021-03-12
    Dose 2 — Moderna
  10. 2021-03-12
    Health check-in — day 0, dose 2
    Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  11. 2021-03-13
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dyspnoea, Heart rate irregular — Feeling: Fair · Site: Pain, Swelling · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Increase in irregular heartbeat, shortness of breath last night, normal when woke this morning.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-03-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Itching · None
    Adult check-in
  13. 2021-03-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  14. 2021-03-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-03-18
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-03-19
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-03-28
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-04-02
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-04-09
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-04-17
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-04-23
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-06-11
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-09-14
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-12-02
    Dose 3 — Moderna
    Co-administered: Flu
  25. 2022-03-12
    Survey response — 12 months, dose 2
    MedDRA: Cardiac ablation, Cardiac failure, Ejection fraction decreased, Hospitalisation, Office visit, Pre-existing disease, Supraventricular tachycardia — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization
    Free text: Hospitalized with SVT, 2/16, successful ablation 2/18. Chronic problem since 1994. Caused return of heart failure. EF 40%. 3/3 nuclear stress test showed no coronary blockage. Continuing treatment w/ heart failure doctor.
    MedDRA releases: 2024-11 · check-in free text available
  26. 2022-03-12
    Report sent to call center — 12 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Emergency room or emergency department visit · Hospitalization · 1 call case(s)
  27. 2022-03-15
    Call successful
    Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
  28. 2022-08-09
    Dose 4 — Moderna
  29. 2022-11-07
    Dose 5 — Moderna
    Co-administered: Flu
  30. 2022-11-09
    Health check-in — days 1–6 daily, dose 5
    Feeling: Fair · Site: Pain, Redness, Swelling · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  31. 2022-11-11
    Health check-in — days 1–6 daily, dose 5
    Feeling: Fair · Site: Itching · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  32. 2022-11-12
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · Site: Pain, Itching · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  33. 2022-11-13
    Health check-in — days 1–6 daily, dose 5
    Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  34. 2022-11-16
    Health check-in — day 7, dose 5
    Feeling: Poor · Fever · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  35. 2022-11-21
    Health check-in — day 14, dose 5
    Feeling: Fair
    Adult check-in
  36. 2022-11-28
    Survey response — day 21, dose 5
    MedDRA: Cough, Dysphonia, Fatigue, Nasopharyngitis, Rhinorrhoea, Sneezing, Throat irritation — Feeling: Good · Be unable to do your normal daily activities
    Free text: Cold; 2wks & counting. Respiratory only: runny nose, sneezing, dry tickling cough. Clear discharge. Extreme fatigue 1st wk. Hoarseness in last 5 days. NO fever, chills, sore throat, congestion, headache, or muscle/joint pain.
    MedDRA releases: 2024-11 · check-in free text available
  37. 2022-12-05
    Health check-in — day 28, dose 5
    Feeling: Good
    Adult check-in
  38. 2022-12-12
    Survey response — day 35, dose 5
    MedDRA: Cough, Laryngitis — Feeling: Fair
    Free text: Laryngitis and dry cough returned.
    MedDRA releases: 2024-11 · check-in free text available
  39. 2022-12-19
    Health check-in — day 42, dose 5
    Feeling: Good
    Adult check-in
  40. 2023-02-06
    Health check-in — 3 months, dose 5
    Feeling: Fair
    Adult check-in
  41. 2023-05-08
    Health check-in — 6 months, dose 5
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-02-12Moderna
22021-03-12Moderna
32021-12-02Moderna Flu
42022-08-09Moderna No
52022-11-07Moderna Flu

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 5 — days 1–6 daily, dose 2

2021-03-13

Systemic reaction (other): Increase in irregular heartbeat, shortness of breath last night, normal when woke this morning.

Release 11 — 12 months, dose 2

2022-03-12

Symptoms: Hospitalized with SVT, 2/16, successful ablation 2/18. Chronic problem since 1994. Caused return of heart failure. EF 40%. 3/3 nuclear stress test showed no coronary blockage. Continuing treatment w/ heart failure doctor.

Release 12 — day 21, dose 5

2022-11-28

Symptoms: Cold; 2wks & counting. Respiratory only: runny nose, sneezing, dry tickling cough. Clear discharge. Extreme fatigue 1st wk. Hoarseness in last 5 days. NO fever, chills, sore throat, congestion, headache, or muscle/joint pain.

Release 12 — day 35, dose 5

2022-12-12

Symptoms: Laryngitis and dry cough returned.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCardiac ablation · · ✓
SDCardiac failure · · ✓
SDCough · · ✓
SDDysphonia · · ✓
SDEjection fraction decreased · · ✓
SDFatigue · · ✓
SDHospitalisation · · ✓
SDLaryngitis · · ✓
SDNasopharyngitis · · ✓
SDOffice visit · · ✓
SDPre-existing disease · · ✓
SDRhinorrhoea · · ✓
SDSneezing · · ✓
SDSupraventricular tachycardia · · ✓
SDThroat irritation · · ✓
SRODyspnoea ✓ ✓ ✓
SROHeart rate irregular ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release